ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.906,94
-1,07%
Dow Jones
42.573,73
-0,97%
Euro vs US Dollar
1,04197
0,13%
Bitcoin
93.873,30
1,31%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Spyre Therapeutics Inc (SYRE) Börsenkurse

Spyre Therapeutics Inc

Spyre Therapeutics Inc (SYRE)

NASDAQ
22,54
-1,13
(-4,77%)
Geschlossen 31 Dezember 10:00PM
Verzögert um 15 Minuten
22,54
0,00
( 0,00% )
Vor Marktöffnung: 10:05AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
22,54
Gebot
9,02
Fragen
36,06
Volumen
3
0,00 Tagesbereich 0,00
18,54 52-Wochen-Bereich 47,97
Marktkapitalisierung
1,159B
Handelsende
22,54
Handelsbeginn
-
Letzte Trade
1
@
25.8
Letzter Handelszeitpunkt
10:36:44
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
538.007
Ausgegebene Aktien
51.431.220
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,82
Gewinn pro Aktie (EPS)
-6,59
Erlöse
886k
Nettogewinn
-338,79M

Über Spyre Therapeutics Inc

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.spyre.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Spyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SYRE. The last closing price for Spyre Therapeutics was US$22,54. Over the last year, Spyre Therapeutics shares have traded in a share price range of US$ 18,54 to US$ 47,97.

Spyre Therapeutics currently has 51.431.220 shares in issue. The market capitalisation of Spyre Therapeutics is US$1,16 billion. Spyre Therapeutics has a price to earnings ratio (PE ratio) of -1.82.

SYRE Neueste Nachrichten

Weitere Nachrichten

Spyre Therapeutics Added to the Nasdaq Biotechnology Index

Spyre Therapeutics Added to the Nasdaq Biotechnology Index PR Newswire WALTHAM, Mass., Dec. 18, 2024 WALTHAM, Mass., Dec. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a...

18 Dezember 2024
PR Newswire (US)

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Dec. 2, 2024 WALTHAM, Mass., Dec. 2, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...

02 Dezember 2024
PR Newswire (US)

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies PR Newswire WALTHAM, Mass., Dec. 2, 2024 Spyre is concurrently advancing...

02 Dezember 2024
PR Newswire (US)

Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference PR Newswire WALTHAM, Mass., Nov. 25, 2024 WALTHAM, Mass., Nov. 25, 2024 /PRNewswire/ -- Spyre Therapeutics...

25 November 2024
PR Newswire (US)

Form 8-K - Current report

19 November 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

19 November 2024
Edgar (US Regulatory)

Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics...

19 November 2024
PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]

18 November 2024
Edgar (US Regulatory)

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre...

18 November 2024
PR Newswire (US)

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

18 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.04-4.4105173876223.5825.9922.3729697823.36093136CS
4-5.04-18.274111675127.5829.0622.3748700924.85423532CS
12-4.96-18.036363636427.540.122.3753800729.25728092CS
26-1.17-4.9346267397723.7140.122.3751973828.6298395CS
520.552.501136880421.9947.9718.5452257329.58874926CS
15611.73108.51063829810.8147.9710.4249111029.29201321CS
26011.73108.51063829810.8147.9710.4249111029.29201321CS

SYRE - Frequently Asked Questions (FAQ)

What is the current Spyre Therapeutics share price?
The current share price of Spyre Therapeutics is US$ 22,54
How many Spyre Therapeutics shares are in issue?
Spyre Therapeutics has 51.431.220 shares in issue
What is the market cap of Spyre Therapeutics?
The market capitalisation of Spyre Therapeutics is USD 1,16B
What is the 1 year trading range for Spyre Therapeutics share price?
Spyre Therapeutics has traded in the range of US$ 18,54 to US$ 47,97 during the past year
What is the PE ratio of Spyre Therapeutics?
The price to earnings ratio of Spyre Therapeutics is -1,82
What is the cash to sales ratio of Spyre Therapeutics?
The cash to sales ratio of Spyre Therapeutics is 698,26
What is the reporting currency for Spyre Therapeutics?
Spyre Therapeutics reports financial results in USD
What is the latest annual turnover for Spyre Therapeutics?
The latest annual turnover of Spyre Therapeutics is USD 886k
What is the latest annual profit for Spyre Therapeutics?
The latest annual profit of Spyre Therapeutics is USD -338,79M
What is the registered address of Spyre Therapeutics?
The registered address for Spyre Therapeutics is 1521 CONCORD PIKE, SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803
What is the Spyre Therapeutics website address?
The website address for Spyre Therapeutics is www.spyre.com
Which industry sector does Spyre Therapeutics operate in?
Spyre Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EYENEyenovia Inc
US$ 0,266
(134,77%)
36,83M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,242
(95,79%)
15,2M
APMAptorum Group Ltd
US$ 2,59
(91,14%)
1,18M
ASNSActelis Networks Inc
US$ 2,16
(66,15%)
1,55M
NXUNXU Inc
US$ 2,33
(55,33%)
10,22M
SGMOSangamo Therapeutics Inc
US$ 1,19
(-49,15%)
363,03k
WATTEnergous Corporation
US$ 1,72
(-35,09%)
1,04M
XOMAXOMA Royalty Corporation
US$ 20,11
(-22,92%)
1
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 40,98
(-22,71%)
409,34k
RGFReal Good Food Company Inc
US$ 0,25
(-22,09%)
1,09k
EYENEyenovia Inc
US$ 0,266
(134,77%)
36,83M
SVMHSRIVARU Holding Ltd
US$ 0,041
(22,75%)
30,84M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,242
(95,79%)
15,2M
CRKNCrown Electrokinetics Corporation
US$ 0,1689
(21,77%)
14,22M
NXUNXU Inc
US$ 2,33
(55,33%)
10,22M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
SYRE
Spyre Therapeutics
OKEX
API3USDT
API3
OKEX
AAVEBTC
Aave Token
ASX
WES
Wesfarmers
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten